Johnson FM, O'Hara MP, Yapindi L, Jiang P, et al. Phase 1/2 Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas. Clin Cancer Res 2024 Nov 26. doi: 10.1158/1078-0432.CCR-24-2290.
PMID: 39589337